Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)

Not Applicable

Completed

Conditions: Fitness Trackers
Breast Cancer Survivor
Breast Cancer

Interventions: Other: Move Together app/Garmin Activity Tracker

Registration Number: NCT05011279

Lead Sponsor: Dana-Farber Cancer Institute

Brief Summary: The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.

Detailed Description: The purpose of this study is to develop and test a mobile app for Black/African American breast cancer survivors and their relatives, called Move Together, that promotes sitting less and moving more for better health.

This is a cross-sectional descriptive study using structured interviews and qualitative data analysis to develop an intervention, followed by a pilot test of the intervention with pre- /post- measures.

* In study phase 1,involved qualitative interviews with 5 community leader key informants, 9 breast cancer survivors and 6 first degree relatives of a survivor.

* This part of the research study is a Pilot Study, which means it is the first time that researchers are studying usability and acceptability of the Move Together app.

* Participants in the pilot study will participate as members of family-based dyads (n=10 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative

* Study involves screening for eligibility, interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

* Participation on the trial will be for 5 weeks

* About 20 people (10 survivors with 10 relatives) will participate in this part of the study, and a total of 58 people in the whole study.

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 10

Inclusion Criteria

1a) Key informants (for interviews)
- Members of the community/advisory groups, community health centers, or faith-based network members (e.g., Pink and Black, Faces of Faith).
- English speaking adults.
(1b) Breast cancer survivors and relatives (for interviews)
- Self-identify as Black or African American
- Age 18 and over
- English speaking
- Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor
- Self-report ever using a smart phone
(2) Breast cancer survivors and relatives (for user testing/interviews)
- Self-identify as Black or African American
- Age 18 and over
- English speaking
- Female breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a first degree blood relative (parent, child, or full sibling), of any gender, of a so defined breast cancer survivor
- Self-report willing/able to download the app for testing on a smart phone
- Self-report willing/able to meet via Zoom for interview
(3) Breast cancer survivors and relatives/"buddies" (for pilot testing)
- Self-identify as Black or African American
- Age 18 and over
- English speaking
- Breast cancer survivor status post curative antineoplastic treatment (except ongoing hormonal treatment) with no evidence of disease, OR a blood relative, of any gender, of a so defined breast cancer survivor
- Self-report willing/able to participate with a blood relative in survivor relative dyad
- Self-report willing/able to download the app for use on a smart phone
- Self-report willing/able to meet via Zoom for instructions and interview

Exclusion Criteria

(1a) Key informants (for interviews)

--None
(1b) Breast cancer survivors and relatives (for interviews)
- Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7)
- Pregnant women
(2) Breast cancer survivors and relatives (for user testing/interviews)
- Requires medically supervised physical activity (Physical Activity Readiness Question for Everyone, PAR-Q+, Question 7)
- Pregnant women
(3) Breast cancer survivors and relatives/"buddies" (for pilot testing)
- Meets exclusion criterion of the Modified Physical Activity Readiness Questionnaire (PAR-Q) (modified)
- Participated in interviews or user testing in prior phases of the study

Study & Design

Study Type: INTERVENTIONAL

Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Pilot Study	Move Together app/Garmin Activity Tracker	Participants in the pilot study will participate as members of family-based dyads (n=5 dyads). One member of each dyad will be a breast cancer survivor and one will be a blood relative. Study involves interviews, questionnaires, Use of Move Together app with Garmin activity tracker watch

Primary Outcome Measures

Name	Time	Method
System Usability Scale (SUS) Score	Assessed at 4 Weeks	The acceptability of the Move Together app will also be assessed with The System Usability Scale (SUS) score. The scale has 10 items. Scores range from 0-100; a SUS score above a 68 is considered above average (https://www.usability.gov/how-to-and-tools/methods/system-usability-scale.html.)

Secondary Outcome Measures

Name	Time	Method
Number of Participants Screened Per Month	4 month recruitment period	the number of participants screened per month during recruitment period (not cumulative)
Number of Participants Enrolled Per Month	4 month enrollment period	number of participants consented to the study each month during enrollment period
Number of Participants Completed Study	4 weeks	Total number of participants who completed the study
Number of Participants Retained at the End of 4 Weeks	Baseline to 4 Weeks	Retention will be the number who remain in the study at the end of 4 weeks
Completion Rate	4 Weeks	number of participants who completed all aspects of the protocol
Number of Study Days	baseline to 4 weeks (28 days)	number of study days in which the participants uses the Move Together app and will describe engagement with the app in a 28 day period (i.e., study days)
Number of Participants Recruited	during 4 month recruitment period	Number of initial respondents who consent and enroll.

Trial Locations

Locations (3): University of Rochester
🇺🇸
Rochester, New York, United States
Dana Farber Cancer Institute
🇺🇸
Boston, Massachusetts, United States
University of Massachusetts Boston
🇺🇸
Boston, Massachusetts, United States